semaglutide news october 16 2025 The FDA has approved Wegovy (semaglutide) as a treatment for metabolic-associated steatohepatitis (MASH) with moderate-to-advanced scarring, a serious liver condition affecting approximately 6% of US adults. Key highlights of drug development program FDA approves Wegovy pill |

Radiofrequency Microneedling: Treatments such as Potenza combine traditional microneedling with radiofrequency energy to stimulate collagen and elastin production, improving skin texture, firmness, and overall appearance

While oral forms of semaglutide currently show less total weight loss than injectables in clinical trials, the improved absorption of sublingual drops makes them a powerful and viable option for many individuals

Gastroparesis is delayed gastric emptying without a mechanical obstruction

Vascular endothelial cells Vascular endothelial cells play a key role in responding to injury by rapidly and robustly revascularizing the injured area, which is required for efficient heart regeneration 93